Fortrea Holdings Inc. (FTRE) NASDAQ

10.56

-0.16(-1.49%)

Updated at March 02 04:00PM

Currency In USD

Fortrea Holdings Inc.

Address

8 Moore Drive

Durham, NC 27709

United States of America

Phone

(480)-295-7600

Sector

Healthcare

Industry

Biotechnology

Employees

15000

First IPO Date

June 20, 2023

Key Executives

NameTitlePayYear Born
Anshul ThakralCEO & Director01978
Mark A. MoraisCOO & President of Clinical Services517,0901977
Jill McConnellChief Financial Officer521,3591975
Oren J. CohenChief Medical Officer & President of Clinical Pharmacology01961
Alejandro Martinez GalindoChief Information Officer0N/A
Dave CooperChief Administrative Officer0N/A
Drayton VirklerPresident & Chief Commercial Officer0N/A
J. Stillman HansonGeneral Counsel & Corporate Secretary0N/A
Robert ParksChief Accounting Officer0N/A
Agnieszka GallagherGeneral Counsel01973
Hima InguvaHead of Corporate Development0N/A
Tracy H. KrummeSenior Vice President of Investor Relations01968

Description

Fortrea Holdings Inc., a contract research organization, primarily engages in the provision of biopharmaceutical product and medical device development services worldwide. It operates through two segments: Clinical Services and Enabling Services. The Clinical Services segment provides across the clinical pharmacology and clinical development spectrum. The Enabling Services segment provides patient access and clinical trial technology solutions to customers that streamline complex randomization and optimize the trial drug supply process. The company offers delivery models that include full service, functional service provider, and hybrid service structures. It also offers phase I-IV clinical trial management, differentiated technology enabled trial solutions, and post approval services. The company serves pharmaceutical, biotechnology, and medical device organizations. Fortrea Holdings Inc. was incorporated in 2023 and is based in Durham, North Carolina.